 | • レポートコード：QFJ1-4219 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、女性用医療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、治療、その他）、用途別市場規模（閉経後骨粗鬆症、不妊症、子宮内膜症、PCOS、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・女性用医療の市場動向 ・企業の競争状況、市場シェア ・女性用医療の種類別市場規模と予測2016-2027（医薬品、治療、その他） ・女性用医療の用途別市場規模と予測2016-2027（閉経後骨粗鬆症、不妊症、子宮内膜症、PCOS、その他） ・女性用医療の北米市場規模2016-2027（アメリカ、カナダ） ・女性用医療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・女性用医療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・女性用医療の中南米市場規模2016-2027（メキシコ、ブラジル） ・女性用医療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Veru Inc.、Allergan、Bayer AG、Merck、Pfizer、Teva Pharmaceuticals、Agile Therapeutics、Amgen, Inc.、AstraZeneca、Bristol-Myers Squibb） ・結論 |
Market Analysis and Insights: Global Female Health Market
The global Female Health market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Female Health market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Female Health market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Female Health market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Female Health market.
Global Female Health Scope and Market Size
Female Health market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Female Health market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Medicines
Treatment
Other
Segment by Application
Postmenopausal Osteoporosis
Infertility
Endometriosis
PCOS
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Veru Inc.
Allergan
Bayer AG
Merck
Pfizer
Teva Pharmaceuticals
Agile Therapeutics
Amgen, Inc.
AstraZeneca
Bristol-Myers Squibb
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Female Health Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medicines
1.2.3 Treatment
1.2.4 Other
1.3 Market by Application
1.3.1 Global Female Health Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Postmenopausal Osteoporosis
1.3.3 Infertility
1.3.4 Endometriosis
1.3.5 PCOS
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Female Health Market Perspective (2016-2027)
2.2 Female Health Growth Trends by Regions
2.2.1 Female Health Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Female Health Historic Market Share by Regions (2016-2021)
2.2.3 Female Health Forecasted Market Size by Regions (2022-2027)
2.3 Female Health Industry Dynamic
2.3.1 Female Health Market Trends
2.3.2 Female Health Market Drivers
2.3.3 Female Health Market Challenges
2.3.4 Female Health Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Female Health Players by Revenue
3.1.1 Global Top Female Health Players by Revenue (2016-2021)
3.1.2 Global Female Health Revenue Market Share by Players (2016-2021)
3.2 Global Female Health Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Female Health Revenue
3.4 Global Female Health Market Concentration Ratio
3.4.1 Global Female Health Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Female Health Revenue in 2020
3.5 Female Health Key Players Head office and Area Served
3.6 Key Players Female Health Product Solution and Service
3.7 Date of Enter into Female Health Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Female Health Breakdown Data by Type
4.1 Global Female Health Historic Market Size by Type (2016-2021)
4.2 Global Female Health Forecasted Market Size by Type (2022-2027)
5 Female Health Breakdown Data by Application
5.1 Global Female Health Historic Market Size by Application (2016-2021)
5.2 Global Female Health Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Female Health Market Size (2016-2027)
6.2 North America Female Health Market Size by Type
6.2.1 North America Female Health Market Size by Type (2016-2021)
6.2.2 North America Female Health Market Size by Type (2022-2027)
6.2.3 North America Female Health Market Size by Type (2016-2027)
6.3 North America Female Health Market Size by Application
6.3.1 North America Female Health Market Size by Application (2016-2021)
6.3.2 North America Female Health Market Size by Application (2022-2027)
6.3.3 North America Female Health Market Size by Application (2016-2027)
6.4 North America Female Health Market Size by Country
6.4.1 North America Female Health Market Size by Country (2016-2021)
6.4.2 North America Female Health Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Female Health Market Size (2016-2027)
7.2 Europe Female Health Market Size by Type
7.2.1 Europe Female Health Market Size by Type (2016-2021)
7.2.2 Europe Female Health Market Size by Type (2022-2027)
7.2.3 Europe Female Health Market Size by Type (2016-2027)
7.3 Europe Female Health Market Size by Application
7.3.1 Europe Female Health Market Size by Application (2016-2021)
7.3.2 Europe Female Health Market Size by Application (2022-2027)
7.3.3 Europe Female Health Market Size by Application (2016-2027)
7.4 Europe Female Health Market Size by Country
7.4.1 Europe Female Health Market Size by Country (2016-2021)
7.4.2 Europe Female Health Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Female Health Market Size (2016-2027)
8.2 Asia-Pacific Female Health Market Size by Type
8.2.1 Asia-Pacific Female Health Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Female Health Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Female Health Market Size by Type (2016-2027)
8.3 Asia-Pacific Female Health Market Size by Application
8.3.1 Asia-Pacific Female Health Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Female Health Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Female Health Market Size by Application (2016-2027)
8.4 Asia-Pacific Female Health Market Size by Region
8.4.1 Asia-Pacific Female Health Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Female Health Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Female Health Market Size (2016-2027)
9.2 Latin America Female Health Market Size by Type
9.2.1 Latin America Female Health Market Size by Type (2016-2021)
9.2.2 Latin America Female Health Market Size by Type (2022-2027)
9.2.3 Latin America Female Health Market Size by Type (2016-2027)
9.3 Latin America Female Health Market Size by Application
9.3.1 Latin America Female Health Market Size by Application (2016-2021)
9.3.2 Latin America Female Health Market Size by Application (2022-2027)
9.3.3 Latin America Female Health Market Size by Application (2016-2027)
9.4 Latin America Female Health Market Size by Country
9.4.1 Latin America Female Health Market Size by Country (2016-2021)
9.4.2 Latin America Female Health Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Female Health Market Size (2016-2027)
10.2 Middle East & Africa Female Health Market Size by Type
10.2.1 Middle East & Africa Female Health Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Female Health Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Female Health Market Size by Type (2016-2027)
10.3 Middle East & Africa Female Health Market Size by Application
10.3.1 Middle East & Africa Female Health Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Female Health Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Female Health Market Size by Application (2016-2027)
10.4 Middle East & Africa Female Health Market Size by Country
10.4.1 Middle East & Africa Female Health Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Female Health Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Veru Inc.
11.1.1 Veru Inc. Company Details
11.1.2 Veru Inc. Business Overview
11.1.3 Veru Inc. Female Health Introduction
11.1.4 Veru Inc. Revenue in Female Health Business (2016-2021)
11.1.5 Veru Inc. Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Female Health Introduction
11.2.4 Allergan Revenue in Female Health Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Female Health Introduction
11.3.4 Bayer AG Revenue in Female Health Business (2016-2021)
11.3.5 Bayer AG Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Female Health Introduction
11.4.4 Merck Revenue in Female Health Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Female Health Introduction
11.5.4 Pfizer Revenue in Female Health Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Teva Pharmaceuticals
11.6.1 Teva Pharmaceuticals Company Details
11.6.2 Teva Pharmaceuticals Business Overview
11.6.3 Teva Pharmaceuticals Female Health Introduction
11.6.4 Teva Pharmaceuticals Revenue in Female Health Business (2016-2021)
11.6.5 Teva Pharmaceuticals Recent Development
11.7 Agile Therapeutics
11.7.1 Agile Therapeutics Company Details
11.7.2 Agile Therapeutics Business Overview
11.7.3 Agile Therapeutics Female Health Introduction
11.7.4 Agile Therapeutics Revenue in Female Health Business (2016-2021)
11.7.5 Agile Therapeutics Recent Development
11.8 Amgen, Inc.
11.8.1 Amgen, Inc. Company Details
11.8.2 Amgen, Inc. Business Overview
11.8.3 Amgen, Inc. Female Health Introduction
11.8.4 Amgen, Inc. Revenue in Female Health Business (2016-2021)
11.8.5 Amgen, Inc. Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Female Health Introduction
11.9.4 AstraZeneca Revenue in Female Health Business (2016-2021)
11.9.5 AstraZeneca Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Female Health Introduction
11.10.4 Bristol-Myers Squibb Revenue in Female Health Business (2016-2021)
11.10.5 Bristol-Myers Squibb Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Female Health Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medicines
Table 3. Key Players of Treatment
Table 4. Key Players of Other
Table 5. Global Female Health Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Female Health Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Female Health Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Female Health Market Share by Regions (2016-2021)
Table 9. Global Female Health Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Female Health Market Share by Regions (2022-2027)
Table 11. Female Health Market Trends
Table 12. Female Health Market Drivers
Table 13. Female Health Market Challenges
Table 14. Female Health Market Restraints
Table 15. Global Female Health Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Female Health Market Share by Players (2016-2021)
Table 17. Global Top Female Health Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Health as of 2020)
Table 18. Ranking of Global Top Female Health Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Female Health Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Female Health Product Solution and Service
Table 22. Date of Enter into Female Health Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Female Health Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Female Health Revenue Market Share by Type (2016-2021)
Table 26. Global Female Health Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Female Health Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Female Health Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Female Health Revenue Market Share by Application (2016-2021)
Table 30. Global Female Health Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Female Health Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Female Health Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Female Health Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Female Health Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Female Health Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Female Health Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Female Health Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Female Health Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Female Health Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Female Health Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Female Health Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Female Health Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Female Health Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Female Health Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Female Health Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Female Health Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Female Health Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Female Health Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Female Health Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Female Health Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Female Health Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Female Health Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Female Health Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Female Health Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Female Health Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Female Health Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Female Health Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Female Health Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Female Health Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Female Health Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Female Health Market Size by Country (2022-2027) & (US$ Million)
Table 62. Veru Inc. Company Details
Table 63. Veru Inc. Business Overview
Table 64. Veru Inc. Female Health Product
Table 65. Veru Inc. Revenue in Female Health Business (2016-2021) & (US$ Million)
Table 66. Veru Inc. Recent Development
Table 67. Allergan Company Details
Table 68. Allergan Business Overview
Table 69. Allergan Female Health Product
Table 70. Allergan Revenue in Female Health Business (2016-2021) & (US$ Million)
Table 71. Allergan Recent Development
Table 72. Bayer AG Company Details
Table 73. Bayer AG Business Overview
Table 74. Bayer AG Female Health Product
Table 75. Bayer AG Revenue in Female Health Business (2016-2021) & (US$ Million)
Table 76. Bayer AG Recent Development
Table 77. Merck Company Details
Table 78. Merck Business Overview
Table 79. Merck Female Health Product
Table 80. Merck Revenue in Female Health Business (2016-2021) & (US$ Million)
Table 81. Merck Recent Development
Table 82. Pfizer Company Details
Table 83. Pfizer Business Overview
Table 84. Pfizer Female Health Product
Table 85. Pfizer Revenue in Female Health Business (2016-2021) & (US$ Million)
Table 86. Pfizer Recent Development
Table 87. Teva Pharmaceuticals Company Details
Table 88. Teva Pharmaceuticals Business Overview
Table 89. Teva Pharmaceuticals Female Health Product
Table 90. Teva Pharmaceuticals Revenue in Female Health Business (2016-2021) & (US$ Million)
Table 91. Teva Pharmaceuticals Recent Development
Table 92. Agile Therapeutics Company Details
Table 93. Agile Therapeutics Business Overview
Table 94. Agile Therapeutics Female Health Product
Table 95. Agile Therapeutics Revenue in Female Health Business (2016-2021) & (US$ Million)
Table 96. Agile Therapeutics Recent Development
Table 97. Amgen, Inc. Company Details
Table 98. Amgen, Inc. Business Overview
Table 99. Amgen, Inc. Revenue in Female Health Business (2016-2021) & (US$ Million)
Table 100. Amgen, Inc. Recent Development
Table 101. AstraZeneca Company Details
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Female Health Product
Table 104. AstraZeneca Revenue in Female Health Business (2016-2021) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. Bristol-Myers Squibb Company Details
Table 107. Bristol-Myers Squibb Business Overview
Table 108. Bristol-Myers Squibb Female Health Product
Table 109. Bristol-Myers Squibb Revenue in Female Health Business (2016-2021) & (US$ Million)
Table 110. Bristol-Myers Squibb Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Female Health Market Share by Type: 2020 VS 2027
Figure 2. Medicines Features
Figure 3. Treatment Features
Figure 4. Other Features
Figure 5. Global Female Health Market Share by Application: 2020 VS 2027
Figure 6. Postmenopausal Osteoporosis Case Studies
Figure 7. Infertility Case Studies
Figure 8. Endometriosis Case Studies
Figure 9. PCOS Case Studies
Figure 10. Other Case Studies
Figure 11. Female Health Report Years Considered
Figure 12. Global Female Health Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Female Health Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Female Health Market Share by Regions: 2020 VS 2027
Figure 15. Global Female Health Market Share by Regions (2022-2027)
Figure 16. Global Female Health Market Share by Players in 2020
Figure 17. Global Top Female Health Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Health as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Female Health Revenue in 2020
Figure 19. Global Female Health Revenue Market Share by Type (2016-2021)
Figure 20. Global Female Health Revenue Market Share by Type (2022-2027)
Figure 21. North America Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Female Health Market Share by Type (2016-2027)
Figure 23. North America Female Health Market Share by Application (2016-2027)
Figure 24. North America Female Health Market Share by Country (2016-2027)
Figure 25. United States Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Female Health Market Share by Type (2016-2027)
Figure 29. Europe Female Health Market Share by Application (2016-2027)
Figure 30. Europe Female Health Market Share by Country (2016-2027)
Figure 31. Germany Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Female Health Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Female Health Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Female Health Market Share by Region (2016-2027)
Figure 41. China Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Female Health Market Share by Type (2016-2027)
Figure 49. Latin America Female Health Market Share by Application (2016-2027)
Figure 50. Latin America Female Health Market Share by Country (2016-2027)
Figure 51. Mexico Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Female Health Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Female Health Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Female Health Market Share by Country (2016-2027)
Figure 57. Turkey Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Female Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Veru Inc. Revenue Growth Rate in Female Health Business (2016-2021)
Figure 61. Allergan Revenue Growth Rate in Female Health Business (2016-2021)
Figure 62. Bayer AG Revenue Growth Rate in Female Health Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Female Health Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Female Health Business (2016-2021)
Figure 65. Teva Pharmaceuticals Revenue Growth Rate in Female Health Business (2016-2021)
Figure 66. Agile Therapeutics Revenue Growth Rate in Female Health Business (2016-2021)
Figure 67. Amgen, Inc. Revenue Growth Rate in Female Health Business (2016-2021)
Figure 68. AstraZeneca Revenue Growth Rate in Female Health Business (2016-2021)
Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Female Health Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の女性用不妊治療薬市場規模・現状・予測（2021年-2027年） Female infertility refers to infertility in women. It affects an estimated 48 million women,with the highest prevalence of infertility affecting people in South Asia, Sub-Saharan Africa, North Africa/Middle East, and Central/Eastern Europe and Central Asia. The adverse effects and high cost of non-t…- 世界の女性性機能障害治療市場規模・現状・予測（2021年-2027年） Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm. The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market…
- 世界の女性用衛生製品市場規模・現状・予測（2021年-2027年） Feminine hygiene products are personal care products used by women, constructed in layers of quilted cotton fabrics and alternative layers of super absorbent polymers and plastics, which is impermeable to liquids. These products include sanitary napkins/pads, tampons, panty liners, feminine hygiene …
- 世界の女性不妊症治療薬産業調査2019-2025 Female Infertility Drugs are usually prescribed to women as they're mostly used to help with ovulation problems.In 2018, the global Female Infertility Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been consi…
- 世界の女性不妊症治療薬産業調査2019-2025 Female Infertility Drugs are usually prescribed to women as they're mostly used to help with ovulation problems.In 2018, the global Female Infertility Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been consi…